Acute generalized exanthematous pustulosis

L12_AGEP

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L27.0#, L53.8 Hospital discharge: ICD-9 — 6959X Hospital discharge: ICD-8 — 69599 Cause of death: ICD-10 — L27.0#, L53.8 Cause of death: ICD-9 — 6959X Cause of death: ICD-8 — 69599 2 out of 7 registries used, show all original rules.	1691
4. Check minimum number of events None	1691
5. Include endpoints None	1691
6. Filter based on genotype QC (FinnGen only)	1691

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	L12_AGEP
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L270\|L538
HD_ICD_9	6959X
HD_ICD_8	69599
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L270\|L538
COD_ICD_9	6959X
COD_ICD_8	69599
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute generalized exanthematous pustulosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Generalized skin eruption due to drugs and medicaments

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1691	1109	582
Unadjusted period prevalence (%)	0.34	0.38	0.26
Median age at first event (years)	54.97	52.29	60.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1515: Matched controls
15151

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

6234.8

323.0

1318

L53.8

ICD-10 Finland

Other specified erythematous conditions

309.2

139.9

140

H02AB06

ATC

prednisolone; systemic

3.6

119.3

964

4965

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.6

107.9

355

785

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.6

73.5

284

722

XQ800

NOMESCO Finland

Prick test

4.9

72.1

260

614

R06AE07

ATC

cetirizine; oral

2.5

64.5

825

4851

J01FF01

ATC

clindamycin; systemic

2.8

64.5

543

2511

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.1

59.0

395

1557

E0000UV

ATC

2.4

55.7

738

4300

L50.0

ICD-10 Finland

Allergic urticaria

8.9

55.2

122

148

XQ802

NOMESCO Finland

Epicutan test

6.1

53.8

155

278

69599

ICD-8 Finland

Erythematous condition, Other and unspecified

+∞

52.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

50.5

738

4436

D07AC01

ATC

betamethasone; topical

2.4

50.5

609

3332

XQ820

NOMESCO Finland

Exposure to medicinal substance

31.2

45.2

R50.9

ICD-10 Finland

Fever, unspecified

2.9

44.9

312

1234

D07AB08

ATC

desonide; topical

3.2

43.4

257

910

T78.4

ICD-10 Finland

Allergy, unspecified

4.8

42.2

148

332

XQ899

NOMESCO Finland

Other assessment of skin

20.7

36.3

L50.9

ICD-10 Finland

Urticaria, unspecified

5.2

35.9

116

237

E000001

ATC

2.3

35.2

396

2016

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

34.2

219

808

A02BC02

ATC

pantoprazole; systemic

2.0

33.4

979

7317

D07AA02

ATC

hydrocortisone; topical

2.5

31.4

283

1278

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

6.7

30.7

125

A46

ICD-10 Finland

Erysipelas

2.6

30.1

246

1051

C01CA24

ATC

epinephrine; parenteral

3.4

29.9

153

481

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

29.7

353

1825

J01MA12

ATC

levofloxacin; systemic

2.3

29.4

317

1565

XQ801

NOMESCO Finland

Intracutantest

20.0

27.5

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

27.2

526

3294

D07AC13

ATC

mometasone; topical

2.0

26.6

464

2792

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

26.1

474

2891

J01DB01

ATC

cefalexin; oral

2.0

25.2

1234

10441

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.1

25.1

100

254

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.5

24.8

215

943

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.7

24.4

181

728

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

23.8

366

2085

J01MA14

ATC

moxifloxacin; systemic

2.8

23.3

163

632

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.6

23.2

109

320

L04AX01

ATC

azathioprine; systemic

3.6

22.4

105

307

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

22.4

107

318

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

22.2

239

1166

H02AB07

ATC

prednisone; oral

2.2

22.1

247

1225

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

6.2

22.1

100

ZX120

NOMESCO Finland

Intravenous

2.6

22.1

178

748

ZX108

NOMESCO Finland

Inhalation

14.7

21.7

N02AX02

ATC

tramadol; systemic, rectal

1.7

21.6

608

4224

P01BA02

ATC

hydroxychloroquine; oral

2.6

21.3

165

678

H02AB02

ATC

dexamethasone; systemic

2.5

20.5

175

758

D07AD01

ATC

clobetasol; topical

2.1

20.3

244

1247

J01MA02

ATC

ciprofloxacin; systemic

1.7

20.3

568

3923

A04AA01

ATC

ondansetron; systemic, rectal

3.0

19.9

123

439

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

19.6

336

1972

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

11.9

19.3

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

19.0

214

D02AX

ATC

Other emollients and protectives

3.9

19.0

209

L04AD01

ATC

ciclosporin; systemic

5.8

19.0

E000003

ATC

3.3

19.0

100

321

N03AG01

ATC

valproic acid; systemic, rectal

2.9

18.8

117

421

J01DA01

ATC

[U] cefalexin; systemic

1.6

18.7

924

7401

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.8

18.6

121

448

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

18.6

425

2741

L04AA06

ATC

mycophenolic acid; systemic

6.7

18.5

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

18.3

258

N02AA05

ATC

oxycodone; systemic

2.1

18.1

218

1110

TQW80

NOMESCO Finland

Local dermatologic skincare

4.4

18.1

155

N02BE01

ATC

paracetamol; systemic, rectal

1.8

18.1

1256

11025

C03CA01

ATC

furosemide; systemic

1.8

18.0

397

2525

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

18.0

225

1167

R06.0

ICD-10 Finland

Dyspnoea

1.8

17.5

366

2287

L27.2

ICD-10 Finland

Dermatitis due to ingested food

7.4

17.3

H02AB04

ATC

methylprednisolone; systemic

2.0

17.2

233

1248

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

17.0

182

881

L04AX04

ATC

lenalidomide; oral

19.5

16.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

16.8

129

528

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.6

16.7

129

529

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

16.7

224

1193

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.0

16.7

101

357

153

Kela drug reimbursment

Lenalidomid

18.1

16.5

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

18.1

16.5

R03AC02

ATC

salbutamol; inhalant

1.6

16.2

758

5889

E000006

ATC

2.4

16.0

138

600

J05AB11

ATC

valaciclovir; oral

2.0

15.9

208

1093

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.8

15.7

111

J01FA06

ATC

roxithromycin; oral

1.6

15.5

575

4203

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

15.4

331

2078

R06AX27

ATC

desloratadine; oral

1.7

15.4

417

2802

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.5

15.4

124

522

JN4BD

NOMESCO Finland

Extensive body CT

2.2

15.1

165

805

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

14.8

125

537

M04AA01

ATC

allopurinol; systemic

2.1

14.7

181

927

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

14.6

638

4830

J01FA10

ATC

azithromycin; systemic

1.5

14.6

850

6881

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.1

14.5

174

883

N03AF01

ATC

carbamazepine; oral, rectal

2.9

14.5

318

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

14.5

150

E000002

ATC

2.0

14.4

193

1026

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.0

14.3

196

1050

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.1

14.1

270

J01FA09

ATC

clarithromycin; systemic

1.6

14.0

452

3172

J01AA02

ATC

doxycycline; systemic

1.6

14.0

1073

9214

N03AX16

ATC

pregabalin; oral

1.7

13.8

337

2189

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

13.7

516

3756

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.9

13.6

296

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

13.5

147

713

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

13.4

331

2153

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

13.3

177

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.0

13.3

277

P01AB01

ATC

metronidazole; oral, rectal

1.5

13.2

564

4223

Z51.5

ICD-10 Finland

Palliative care

2.7

13.1

357

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

16.9

13.0

L03AA02

ATC

filgrastim; parenteral

3.9

13.0

140

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.6

12.9

166

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

12.9

134

640

R01AD08

ATC

fluticasone; nasal

1.6

12.8

407

2828

XQ848

NOMESCO Finland

Dermatological photography

3.7

12.7

148

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

12.7

248

1502

J05AB01

ATC

aciclovir; systemic

1.7

12.7

311

2017

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

12.6

571

4318

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

12.6

136

658

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.0

12.6

129

6959X

ICD-9 Finland

Erythematous conditions, Unspecified erythematous condition

+∞

12.5

R06AE09

ATC

levocetirizine; oral

1.8

12.5

218

1270

L51.0

ICD-10 Finland

Nonbullous erythema multiforme

24.5

12.5

N03AX14

ATC

levetiracetam; systemic

3.7

12.4

151

R03BA02

ATC

budesonide; inhalant

1.7

12.4

260

1610

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

12.2

132

641

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

12.2

299

1938

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

12.2

290

1865

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

16.0

12.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

12.1

176

962

L26

ICD-10 Finland

Exfoliative dermatitis

18.2

12.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

11.6

614

4776

J02AC01

ATC

fluconazole; systemic

1.5

11.6

567

4340

L50.8

ICD-10 Finland

Other urticaria

4.1

11.5

110

SPAT1263

SPAT

Sampling

1.5

11.5

612

4765

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

11.3

470

3464

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

11.3

131

654

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.5

11.2

154

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

11.1

151

807

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

11.1

126

626

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.1

11.0

105

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

11.0

435

1CX01

NOMESCO Finland

43.6

10.9

B01AB05

ATC

enoxaparin; parenteral

1.5

10.8

398

2849

N03AF02

ATC

oxcarbazepine; oral

3.0

10.7

215

A02BC05

ATC

esomeprazole; systemic

1.5

10.6

530

4050

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

10.6

252

R03DC03

ATC

montelukast; oral

1.7

10.6

228

1415

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

6.4

10.6

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

10.5

106

499

WX002

NOMESCO Finland

Sedation and analgesia

1.7

10.5

264

1716

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

10.4

131

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

10.4

270

1767

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

10.4

348

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

10.4

246

1574

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.4

10.3

WW500

NOMESCO Finland

Blood transfusion

2.7

10.3

269

N03AX12

ATC

gabapentin; oral

1.7

10.3

214

1318

D05BB02

ATC

acitretin; oral

3.7

10.2

118

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

10.2

180

1050

C90.0

ICD-10 Finland

Multiple myeloma

6.3

10.2

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.6

10.1

277

N03AX09

ATC

lamotrigine; oral

2.5

10.1

323

N05BA04

ATC

oxazepam; oral

1.5

10.0

341

2395

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

9.9

246

1589

D07XC01

ATC

betamethasone, combinations; topical

1.8

9.9

162

922

JN4AD

NOMESCO Finland

Body CT examination

2.1

9.9

108

526

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

9.9

131

690

C07AB07

ATC

bisoprolol; oral

1.4

9.8

586

4624

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.1

9.8

166

L27.9

ICD-10 Finland

Dermatitis due to unspecified substance taken internally

55.3

9.7

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

55.3

9.7

C91.4

ICD-10 Finland

Hairy-cell leukaemia

55.3

9.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

9.6

559

4385

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

9.5

360

2582

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

9.5

213

R01AD09

ATC

mometasone; nasal

1.4

9.5

612

4891

AA1AD

NOMESCO Finland

CT of head and brain

1.6

9.5

307

2125

L40.1

ICD-10 Finland

Generalized pustular psoriasis

100.6

9.4

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

9.4

239

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.3

9.4

143

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

9.4

236

1534

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

9.3

241

1579

A03

ICPC

Fever

1.6

9.2

240

1574

Z71.8

ICD-10 Finland

Other specified counselling

1.5

9.2

325

2295

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

9.1

360

S97

ICPC

Chronic ulcer skin

2.3

9.1

360

L04AB04

ATC

adalimumab; parenteral

3.5

9.1

115

M54.5

ICD-10 Finland

Low back pain

1.5

9.1

435

3275

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

9.0

149

851

L50.1

ICD-10 Finland

Idiopathic urticaria

7.1

9.0

L20.0

ICD-10 Finland

Besnier prurigo

2.0

9.0

110

562

H02AB09

ATC

hydrocortisone; systemic

3.2

9.0

143

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.5

8.9

112

L30.3

ICD-10 Finland

Infective dermatitis

2.9

8.9

190

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

8.8

119

634

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.0

8.8

127

Kela drug reimbursment

Transplant complication

4.4

8.7

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

8.7

107

550

SPAT1255

SPAT

Intravenous administration of medicine

2.1

8.7

462

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

8.7

204

1296

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.7

8.7

216

A02BC03

ATC

lansoprazole; oral

1.5

8.7

392

2912

R06AX22

ATC

ebastine; oral

1.6

8.7

235

1553

Z88.1

ICD-10 Finland

Personal history of allergy to other antibiotic agents

50.3

8.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

8.7

187

M05BX04

ATC

denosumab; parenteral

2.4

8.7

318

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

8.6

361

2638

J01XX08

ATC

linezolid; systemic

7.7

8.6

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

8.6

291

S88

ICPC

Dermatitis contact/allergic

3.3

8.6

131

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

8.6

205

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

8.6

168

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

8.6

103

523

D02AE01

ATC

carbamide; topical

2.0

8.6

101

510

L04AA01

ATC

[U] ciclosporin; systemic

3.9

8.6

S18

ICPC

Laceration/cut

1.4

8.4

546

4342

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

8.4

173

1061

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

8.4

124

683

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

8.4

219

1435

A04AA02

ATC

granisetron; systemic, transdermal

2.2

8.4

422

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

8.4

131

735

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

8.4

104

538

ZX112

NOMESCO Finland

Subcutaneous

3.5

8.3

108

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

8.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

8.2

393

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.9

8.2

163

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.8

8.2

193

C08CA01

ATC

amlodipine; oral

1.4

8.1

425

3247

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

8.0

386

2897

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

8.0

175

1092

A28

ICPC

Limited function/disability NOS

1.7

8.0

186

1181

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

8.0

274

1915

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

8.0

298

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

7.3

8.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

7.9

134

M79.6

ICD-10 Finland

Pain in limb

1.4

7.9

474

3707

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.6

7.9

329

Kela drug reimbursment

Lenalidomide

13.1

7.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

7.9

325

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

7.9

174

1091

UJF32

NOMESCO Finland

Coloscopy

1.5

7.8

328

2394

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

7.8

330

2412

L04AA13

ATC

leflunomide; oral

3.0

7.7

151

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

7.7

207

1365

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

7.7

106

569

R60.0

ICD-10 Finland

Localized oedema

1.7

7.7

144

858

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.1

7.6

127

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.9

7.6

SPAT1254

SPAT

Administration of medicine

1.6

7.6

209

1389

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

7.5

134

N05BB01

ATC

hydroxyzine; systemic

2.0

7.5

508

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

7.5

288

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

7.5

R11

ICD-10 Finland

Nausea and vomiting

1.8

7.5

116

651

TK800

NOMESCO Finland

Hemodialysis

3.4

7.4

102

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

7.4

270

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

7.4

406

M25.5

ICD-10 Finland

Pain in joint

1.4

7.4

372

2811

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

7.4

503

TGC00

NOMESCO Finland

Bronchial lavation

3.2

7.4

119

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.4

379

2874

R4110

NOMESCO Finland

Physiotherapy

1.4

7.4

339

2520

M05BA04

ATC

alendronic acid; oral

1.8

7.3

115

647

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

8.4

7.3

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

7.3

196

1292

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

9.4

7.3

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

7.3

107

590

EMB30

NOMESCO Finland

Adenotomy

2.6

7.2

196

N05CF01

ATC

zopiclone; oral

1.4

7.1

411

3183

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

7.1

124

724

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

7.1

174

1119

134

Kela drug reimbursment

General erythroderma

12.1

7.1

A02BA02

ATC

ranitidine; systemic

1.5

7.1

246

1724

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.8

7.0

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

7.0

211

A92

ICPC

Allergy/allergic reaction NOS

2.5

7.0

211

R02

ICPC

Shortness of breath/dyspnoea

1.7

7.0

159

1003

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

7.0

251

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.2

6.9

108

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

6.9

186

1226

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

6.9

142

870

A02BC01

ATC

omeprazole; systemic

1.4

6.9

351

2656

J01CA04

ATC

amoxicillin; systemic

1.4

6.8

1153

10562

S76

ICPC

Skin infection other

2.1

6.8

334

128

Kela drug reimbursment

Cancers of female genital organs

3.5

6.8

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.2

6.8

B01AC04

ATC

clopidogrel; oral

1.6

6.8

180

1184

R51.80

ICD-10 Finland

Headache

1.6

6.8

202

1367

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

6.8

688

5828

WW200

NOMESCO Finland

Immunization

2.6

6.7

185

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

6.7

330

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

6.7

351

2671

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

6.7

539

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

6.6

159

1018

H05AA02

ATC

teriparatide; parenteral

6.5

6.6

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.7

6.6

163

B01AB10

ATC

tinzaparin; parenteral

1.9

6.6

513

M01CB01

ATC

sodium aurothiomalate; parenteral

3.8

6.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

6.6

126

757

R53

ICD-10 Finland

Malaise and fatigue

1.5

6.6

268

1938

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

6.6

211

1452

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

6.6

687

5835

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.3

6.6

R81

ICPC

Pneumonia

2.6

6.5

172

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

6.5

155

991

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

5.0

6.5

R42

ICD-10 Finland

Dizziness and giddiness

1.4

6.5

280

2050

L52

ICD-10 Finland

Erythema nodosum

5.3

6.5

L30.0

ICD-10 Finland

Nummular dermatitis

2.5

6.5

192

J47

ICD-10 Finland

Bronchiectasis

3.5

6.4

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

14.4

6.4

R03AC03

ATC

terbutaline; inhalant

1.6

6.4

186

1248

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.7

6.4

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

6.4

466

3743

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

6.4

429

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.3

6.4

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

6.6

6.3

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

6.3

238

L93.0

ICD-10 Finland

Discoid lupus erythematosus

6.0

6.3

K12.10

ICD-10 Finland

Stomatitis NOS

11.1

6.3

A07AA02

ATC

nystatin; oral

1.9

6.3

449

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

9.3

6.3

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

6.3

294

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

6.2

485

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

6.2

153

986

SPAT1262

SPAT

Handing over of treatment supplies

1.5

6.2

215

1505

A07AA09

ATC

vancomycin; oral

4.5

6.2

X57

ICD-10 Finland

Unspecified privation

3.0

6.1

113

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

6.1

110

646

318

Kela drug reimbursment

Teriparatide

5.8

6.1

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.9

6.1

122

WZC30

NOMESCO Finland

Teaching

1.6

6.1

161

1058

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

6.1

207

1442

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

6.1

174

1164

M03BX02

ATC

tizanidine; oral

1.3

6.1

789

6883

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.9

6.0

L04AC05

ATC

ustekinumab; parenteral

10.1

6.0

N03AX18

ATC

lacosamide; systemic

5.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

26.83

68.18

1.0

1.1

—

(3023368) Bacteria identified in Blood by Culture

665

3503

2.48

67.61

6.2

4.2

—

(3006315) Basophils [#/volume] in Blood

1065

6917

2.46

67.55

11.2

5.8

e9/l

0.0

0.09

971

5969

(3013115) Eosinophils [#/volume] in Blood

1089

7150

2.47

67.32

11.7

6.1

e9/l

0.2

1.96

1003

6271

(3001604) Monocytes [#/volume] in Blood

1060

6888

2.44

66.88

11.2

5.8

e9/l

0.6

0.62

968

5937

(40768443) Skin Pathology biopsy report

205

564

4.00

65.90

1.4

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

1077

7108

2.42

64.68

11.3

5.8

e9/l

1.9

0.04

1002

6263

(42870588) Differential panel, method unspecified - Blood

794

4664

2.32

61.55

11.3

5.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1154

8025

2.38

58.83

16.2

8.9

e9/l

4.2

4.1

1.37

1057

7009

(3019069) Monocytes/100 leukocytes in Blood

989

6532

2.24

55.78

12.3

6.2

8.4

8.5

0.17

937

6110

(3022096) Basophils/100 leukocytes in Blood

961

6290

2.22

55.22

12.1

6.0

0.7

0.10

907

5866

(3005719) IgG [Mass/volume] in Serum or Plasma

279

1046

3.00

54.63

4.4

2.9

g/l

10.2

10.5

0.35

267

955

(3006504) Eosinophils/100 leukocytes in Blood

981

6494

2.22

54.52

12.0

5.9

3.0

2.8

1.23

930

6035

(3002030) Lymphocytes/100 leukocytes in Blood

1003

6726

2.21

53.59

12.1

6.0

26.9

28.2

3.25

949

6268

(3018010) Neutrophils/100 leukocytes in Blood

993

6635

2.20

53.51

11.4

5.8

58.2

57.1

2.03

940

6206

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

112

225

5.26

53.21

2.0

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

131

316

4.41

49.91

2.1

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

117

259

4.78

49.60

7.5

5.6

iu/ml

333.7

301.4

0.07

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

127

310

4.35

47.63

2.1

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

430

2141

2.35

46.71

2.3

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

325

1435

2.57

45.88

6.4

4.1

u/l

245.8

248.0

0.10

304

1355

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1000

6949

2.07

45.50

9.5

6.0

umol/l

10.6

11.3

1.03

964

6579

(3011412) CD3 cells [#/volume] in Blood

124

6.37

44.88

2.9

2.6

e9/l

1.2

1.3

0.30

(3028026) IgM [Mass/volume] in Serum or Plasma

222

821

2.96

44.08

2.4

1.8

g/l

1.2

1.5

1.04

206

759

(3037522) Nuclear Ab [Titer] in Serum

380

1842

2.37

43.55

1.6

1.3

titre

635.2

530.2

0.44

100

389

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

143

410

3.72

42.89

2.8

1.6

g/l

0.2

0.29

133

390

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

7.45

42.55

2.7

2.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

145

423

3.66

42.39

2.7

1.6

g/l

1.2

0.63

138

398

(3017181) Myelocytes/100 leukocytes in Blood

268

1126

2.64

41.61

6.8

4.0

0.9

0.15

134

319

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

954

6673

1.99

40.75

11.2

6.6

mmol/l

1.2

0.64

810

5646

(21494815) CD4 cells/100 lymphocytes in Specimen

106

6.44

39.56

1.9

2.4

40.7

41.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

247

1021

2.66

39.52

6.6

3.9

0.5

0.6

0.16

106

233

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

6.81

39.25

2.6

12.9

11.6

0.22

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

881

6056

1.95

38.93

9.6

6.0

mmol/l

1.2

2.19

807

5483

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1308

10388

2.14

37.31

13.8

7.2

u/l

81.0

78.4

1.00

1259

9752

(3005322) IgE [Units/volume] in Serum or Plasma

223

901

2.70

37.23

1.6

1.3

u/ml

398.8

210.6

1.24

209

824

(3021440) Promyelocytes/100 leukocytes in Blood

248

1068

2.55

36.33

7.0

4.1

0.1

0.49

121

292

(3032080) INR in Blood by Coagulation assay

776

5199

1.91

36.17

9.0

8.8

inr

1.2

0.51

232

1493

(3023520) Reticulocytes [#/volume] in Blood

250

1088

2.52

35.80

4.0

2.8

e9/l

71.0

70.8

0.03

190

834

(3025159) Blasts/100 leukocytes in Blood

236

1000

2.58

35.73

7.0

4.2

0.9

0.4

0.22

109

246

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

175

4.81

35.28

2.1

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

228

964

2.58

34.62

1.9

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

129

5.45

34.34

2.0

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

141

5.21

34.09

2.0

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

147

496

3.15

34.00

2.4

1.9

ug/l

1.3

1.9

0.35

132

439

(3007853) Bacteria identified in Skin by Aerobe culture

321

1602

2.24

33.53

2.0

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

209

4.33

33.22

3.6

3.5

u/ml

704.3

1725.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

302

1484

2.26

32.69

2.2

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

148

4.96

32.25

2.0

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

299

1473

2.25

32.12

2.0

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

824

5788

1.83

31.67

7.9

4.7

g/l

34.6

35.7

5.86

765

5386

(3027945) Reticulocytes/100 erythrocytes in Blood

298

1474

2.24

31.67

3.5

2.8

1.9

1.8

0.37

265

1309

(3042936) Bacteria identified in Isolate by Culture

357

1911

2.10

30.98

2.7

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

6.58

30.80

1.7

1.4

ug/l

7.2

5.9

0.71

(3012095) Magnesium [Moles/volume] in Serum or Plasma

382

2115

2.04

30.18

5.7

3.5

mmol/l

0.8

1.69

363

1971

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

5.77

29.69

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

375

2075

2.04

29.61

2.9

2.4

umol/l

11.9

13.2

3.16

346

1909

(3036481) Cortisol [Moles/volume] in Serum or Plasma

265

1287

2.26

29.29

2.9

2.0

nmol/l

340.6

374.3

1.89

250

1182

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

123

411

3.15

28.86

3.0

2.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1165

9232

1.84

28.71

5.9

4.5

e6/l

30.8

2429.6

—

124

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

330

1764

2.08

28.52

3.0

2.4

21.4

23.0

1.23

279

1507

(3004809) Band form neutrophils/100 leukocytes in Blood

207

4.06

28.49

3.1

3.3

1.6

1.3

0.32

169

(3004789) Transferrin [Mass/volume] in Serum or Plasma

348

1918

2.03

27.58

2.9

2.4

g/l

2.3

1.26

317

1774

(3007164) IgA [Mass/volume] in Serum or Plasma

465

2832

1.89

27.44

2.0

1.5

g/l

2.2

2.3

0.45

325

1707

(3013707) Erythrocyte sedimentation rate by Westergren method

1241

10101

1.86

27.17

7.3

4.0

mm/h

15.2

12.0

9.08

1167

9330

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

126

443

2.99

27.06

1.9

1.6

titre

196.5

146.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

139

517

2.84

26.96

1.4

1.2

u/ml

0.3

1.3

0.99

(3003458) Phosphate [Moles/volume] in Serum or Plasma

324

1754

2.05

26.92

9.1

5.6

mmol/l

1.1

0.74

301

1619

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

709

4925

1.76

26.92

4.4

3.5

ng/l

48.1

43.2

0.16

513

3287

(3037467) Urinalysis macro (dipstick) panel - Urine

1190

9587

1.81

26.64

6.3

4.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

8.29

26.55

1.9

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

210

3.85

25.53

1.9

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1013

7860

1.72

25.12

6.9

4.7

mmol/l

6.7

6.6

0.14

972

7298

(40760892) CBC W Ordered Manual Differential panel - Blood

486

3072

1.82

25.10

8.4

4.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

233

1140

2.21

25.08

11.3

7.3

mmol/l

9.8

9.4

0.39

221

1088

(3000494) Fungus identified in Specimen by Culture

291

1553

2.06

25.00

2.0

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

516

3327

1.79

24.91

4.0

2.6

umol/l

3937.4

5935.0

0.55

455

2882

(3020630) Protein [Mass/volume] in Serum or Plasma

219

1053

2.24

24.58

5.3

2.9

g/l

66.0

66.6

0.49

200

956

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

9.50

24.45

2.0

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

231

3.63

24.40

1.9

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

4.08

24.26

1.9

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

581

3914

1.74

23.88

2.7

2.2

u/l

163.5

230.6

1.46

551

3682

(3018095) Leukocytes [#/volume] in Urine

685

4846

1.70

23.42

4.6

3.6

e6/l

40.4

98.5

2.66

512

3388

(3030467) Casts [#/volume] in Urine by Automated count

559

3747

1.73

23.26

4.0

3.1

e6/l

0.3

0.4

0.62

453

2833

(3017143) Hepatitis C virus Ab [Presence] in Serum

300

1660

1.98

23.16

2.1

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

549

3668

1.74

23.08

3.6

3.0

ng/l

1625.0

1242.7

0.99

474

3097

(3021879) Hepatitis B virus core Ab [Presence] in Serum

213

1040

2.20

22.96

1.6

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

603

4147

1.71

22.74

3.5

2.4

u/l

54.1

56.7

1.16

565

3825

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

5.06

22.61

3.5

2.7

e6/l

603.2

587.4

0.05

(3018418) pH of Serum or Plasma

580

3952

1.71

22.61

6.0

3.9

7.4

0.33

117

726

(3035350) Ketones [Presence] in Urine by Test strip

892

6801

1.66

22.60

5.0

3.6

estimate

0.0

0.50

182

1279

(3004588) Protein electrophoresis panel - Serum or Plasma

187

872

2.29

22.52

4.1

2.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

115

426

2.82

22.44

1.7

1.6

iu/ml

3.5

0.2

0.56

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

5.11

22.40

3.6

2.8

e9/l

0.2

0.19

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

529

3523

1.73

22.36

2.8

2.2

mg/l

3.1

3.0

0.91

446

2983

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

169

3.96

22.35

1.8

1.5

—

(36304419) Bacteria [Presence] in Urine

542

3663

1.71

21.56

4.0

3.0

—

(44790047)

160

3.98

21.54

1.9

1.5

—

(44806118)

160

3.98

21.54

1.9

1.5

—

(44790049)

160

3.98

21.54

1.9

1.5

—

(44790048)

160

3.98

21.54

1.9

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

470

3057

1.74

21.46

2.1

1.8

mg/l

1.3

1.1

0.79

374

2324

(3009261) Glucose [Presence] in Urine by Test strip

894

6901

1.63

20.91

5.1

3.6

estimate

0.0

0.80

186

1264

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

276

3.19

20.91

4.3

3.7

59.4

57.0

0.78

276

(3021601) Nitrite [Presence] in Urine by Test strip

887

6834

1.63

20.91

6.6

4.9

estimate

0.0

0.50

193

1302

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

114

437

2.72

20.84

4.0

1.9

—

(3028433) Virus identified in Specimen by Culture

6.92

20.83

1.2

1.4

—

(3021589) Normoblasts [#/volume] in Blood

813

6141

1.62

20.70

17.6

9.1

e9/l

0.0

0.46

694

5016

(40758558) Short blood count panel - Blood

520

3524

1.69

20.22

12.3

6.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

108

411

2.74

20.02

2.8

3.2

g/l

3.7

3.6

0.47

101

390

(3002582) Erythrocytes [#/volume] in Urine

581

4071

1.65

19.78

4.2

3.2

e6/l

29.4

75.0

1.84

478

3137

(3030905) Polymorphonuclear cells [#/volume] in Blood

265

3.16

19.68

3.9

3.5

e9/l

4.4

4.1

0.56

265

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

102

4.61

19.44

2.4

2.3

e6/l

607.5

705.3

0.35

(3044640) Blood type and Crossmatch panel - Blood

614

4380

1.63

19.36

3.3

2.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

119

4.30

19.35

1.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

119

4.30

19.35

1.9

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

119

4.30

19.35

1.9

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

234

1262

1.99

19.22

3.1

2.3

g/l

0.2

0.17

210

1174

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

199

3.46

19.01

1.8

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

438

2880

1.70

18.85

3.5

2.5

e6/l

4.7

6.6

3.55

400

2537

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.72

18.73

2.1

1.6

—

(3037756) Immunofixation for Serum or Plasma

284

3.02

18.69

2.5

1.6

—

(3026782) Osmolality of Urine

417

2711

1.71

18.69

3.8

2.7

mosm/kgh2o

507.4

547.0

3.44

371

2312

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

3.71

18.65

4.1

3.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

131

567

2.42

18.64

2.1

1.9

g/l

1.6

1.5

0.54

118

490

(3017354) Segmented neutrophils/100 leukocytes in Blood

129

4.05

18.23

3.5

2.9

59.1

55.2

0.47

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

758

5746

1.58

18.22

2.8

2.3

nmol/l

75.4

77.0

0.83

696

5159

(3018677) aPTT in Platelet poor plasma by Coagulation assay

329

2030

1.77

17.64

2.6

2.2

29.7

0.01

317

1966

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

380

2.68

17.52

1.4

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1522

13792

2.04

17.28

27.6

13.5

mg/l

21.3

23.0

1.61

1351

10837

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

309

2.84

17.19

1.5

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

128

576

2.32

16.67

2.3

2.0

u/l

38.0

38.9

0.19

114

510

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

378

2.63

16.66

5.6

4.0

ratio

7.8

1.7

0.62

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

106

440

2.50

16.50

2.2

ug/l

174.7

427.4

1.34

414

(3009343) pH of Capillary blood

169

858

2.08

16.32

6.8

4.2

7.4

0.06

(3001122) Ferritin [Mass/volume] in Serum or Plasma

809

6333

1.53

16.17

3.8

2.8

ug/l

161.7

113.6

1.45

745

5858

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

30.35

16.12

1.1

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

115

502

2.39

16.05

1.5

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

368

2.62

15.98

2.3

2.1

mg/l

13.2

11.5

0.61

335

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

293

2.82

15.96

1.7

1.3

u/ml

357.7

234.0

1.83

166

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

282

2.85

15.94

1.8

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

169

867

2.05

15.86

6.8

4.2

kpa

5.1

5.2

0.26

159

815

(3034860) Kappa light chains.free [Mass/volume] in Serum

388

2.56

15.80

5.7

4.0

mg/l

51.7

67.4

0.38

317

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

163

828

2.07

15.70

6.7

4.2

mmol/l

1.7

1.8

0.12

125

626

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

4.69

15.67

3.3

2.6

31.6

43.1

1.80

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

390

2.55

15.64

5.7

4.0

mg/l

45.5

62.2

0.32

320

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

9.14

15.56

1.2

2.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

210

3.13

15.51

2.0

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

475

3329

1.59

15.39

3.2

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

289

2.78

15.24

6.1

4.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

359

2359

1.66

15.06

2.0

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.99

14.80

1.4

—

(3026008) Bacteria identified in Urine by Culture

584

4320

1.54

14.80

3.9

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

415

2842

1.61

14.72

2.2

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

142

3.52

14.48

1.3

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

155

797

2.04

14.43

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

260

2.81

14.19

1.9

1.5

u/ml

119.9

111.6

0.43

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

278

2.74

14.10

1.6

1.2

u/ml

3.3

5.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

355

2.53

14.06

1.6

1.2

u/ml

28.7

7.4

0.96

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

349

2.54

14.06

1.6

1.2

u/ml

17.5

2.5

0.57

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.74

14.04

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

7.48

13.99

2.0

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

381

2.47

13.93

1.6

1.2

u/ml

23.7

37.1

0.32

(40761535) Cells panel - Urine sediment

195

1099

1.88

13.89

4.8

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

682

5268

1.49

13.82

5.4

3.8

—

(3033658) Prothrombin time (PT) actual/Normal

475

3400

1.55

13.79

6.2

3.9

90.5

90.6

0.05

461

3303

(3012544) pH of Venous blood

216

1261

1.82

13.74

5.7

4.2

—

7.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

329

2.57

13.72

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

588

4418

1.51

13.58

5.4

3.1

u/l

33.5

31.3

0.53

556

4210

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

4.16

13.51

1.6

1.4

u/ml

39.4

20.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

448

3180

1.56

13.44

4.6

3.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

170

926

1.93

13.42

2.4

au/ml

21.4

24.8

0.16

(3045142) Bone marrow Pathology biopsy report

150

3.33

13.32

1.6

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

211

1235

1.81

13.29

6.3

4.2

kpa

5.8

0.48

205

1194

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

287

2.65

13.27

1.8

1.4

—

13.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

157

837

1.97

13.20

1.3

au/ml

40.6

43.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

147

766

2.01

13.18

1.9

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

815

6565

1.47

13.15

5.3

4.0

—

(3002032) Base excess in Venous blood by calculation

209

1229

1.80

12.95

6.3

4.2

mmol/l

2.0

1.8

0.48

176

973

(3048689) Calprotectin [Mass/mass] in Stool

276

1765

1.67

12.67

3.1

2.4

ug/g

125.9

114.8

0.32

217

1383

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.97

12.65

2.2

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.97

12.65

2.2

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

214

2.87

12.62

1.1

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

398

2788

1.56

12.55

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.88

12.39

2.3

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

222

2.81

12.37

1.5

1.6

g/l

0.4

0.8

2.65

167

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

335

2262

1.60

12.35

3.1

2.7

e6/l

1.0

1.1

0.31

210

1272

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

117

575

2.11

12.29

8.1

4.6

mmol/l

24.7

24.8

0.15

109

547

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.22

12.27

2.2

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

112

543

2.14

12.19

2.4

1.9

—

(3019060) Gas panel - Arterial blood

153

831

1.92

12.17

5.5

5.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

606

4661

1.47

12.13

4.4

3.4

mmol/l

2.3

2.4

1.73

532

4079

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.35

11.96

2.2

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.35

11.96

2.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.35

11.96

2.2

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.35

11.96

2.2

1.5

—

(1616796) Gas panel - Central venous blood

261

2.63

11.93

4.5

3.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

449

3260

1.51

11.92

1.3

u/ml

1.1

1.6

0.58

105

847

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

256

2.64

11.85

2.1

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

5.41

11.83

2.5

3.4

e6/l

273.6

200.0

0.32

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

103

490

2.17

11.76

2.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.50

11.68

2.4

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

218

2.77

11.64

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

232

1448

1.70

11.62

9.0

7.8

kpa

5.0

5.1

1.04

217

1387

(3027801) Oxygen [Partial pressure] in Arterial blood

232

1448

1.70

11.62

9.0

7.8

kpa

12.4

12.3

0.10

216

1387

(3019309) Folate [Moles/volume] in Red Blood Cells

354

2460

1.56

11.45

1.9

1.7

nmol/l

1214.8

1182.1

0.26

273

1846

(3003396) Base excess in Arterial blood by calculation

231

1450

1.69

11.32

8.9

7.8

mmol/l

1.1

0.06

176

1134

(3029937) Albumin [Presence] in Urine by Test strip

493

3683

1.48

11.28

5.9

3.9

estimate

0.0

1.28

179

1262

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

357

2497

1.54

11.19

4.6

3.7

ng/l

126.2

385.9

3.47

260

1877

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

240

1528

1.67

11.13

4.6

2.8

umol/l

6.5

8.0

0.86

208

1315

(3028192) IgG subclass 2 [Mass/volume] in Serum

131

3.26

11.13

1.5

1.3

g/l

2.0

2.8

1.78

(3027135) IgG subclass 1 [Mass/volume] in Serum

131

3.26

11.13

1.5

1.3

g/l

5.9

7.0

0.88

(3024139) IgG subclass 3 [Mass/volume] in Serum

131

3.26

11.13

1.5

1.3

g/l

0.4

0.04

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

342

2376

1.55

11.03

1.3

iu/ml

25.8

28.8

0.27

104

752

(3016502) Oxygen saturation in Arterial blood

208

1284

1.71

10.82

9.5

8.2

95.8

95.7

0.14

194

1241

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.34

10.78

2.4

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

219

1374

1.68

10.73

4.5

3.2

—

(21494434) Karyotype in Bone marrow

114

3.39

10.71

1.3

—

(4062490)

135

3.16

10.61

1.4

1.3

—

(3020891) Body temperature

102

504

2.09

10.58

6.3

4.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

289

2.41

10.14

1.5

1.4

—

(3022313) Gas panel - Capillary blood

121

648

1.93

10.04

8.3

4.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

266

2.46

10.02

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

140

789

1.84

9.94

8.1

7.3

mmol/l

24.7

24.5

0.32

130

741

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

261

2.47

9.93

1.9

1.4

—

(3025941) Bacteria identified in Stool by Culture

138

775

1.85

9.91

1.6

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

677

5466

1.40

9.81

2.2

2.0

pmol/l

95.9

95.5

0.07

402

2814

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.93

9.79

3.5

2.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.81

9.78

1.1

1.0

—

(3000991) Gas panel - Venous blood

182

1114

1.71

9.75

11.5

8.6

—

(3023419) Bacteria identified in Sputum by Culture

164

2.86

9.74

5.5

2.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

347

2.25

9.63

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

355

2.22

9.54

1.2

titre

38.0

83.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

241

1600

1.59

9.38

10.1

6.8

mmol/l

103.9

104.3

0.66

235

1559

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

359

2.20

9.29

2.1

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

322

2286

1.50

9.25

1.2

1.3

u/ml

13.7

11.3

0.22

121

878

(3019150) Specific gravity of Urine by Refractometry

408

3036

1.45

9.25

5.0

4.0

kg/l

1.0

0.12

438

(3019550) Sodium [Moles/volume] in Serum or Plasma

1500

14001

1.63

9.20

27.7

15.4

mmol/l

139.4

139.6

3.17

1474

13612

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

302

2119

1.52

9.17

3.3

2.9

e6/l

4.4

2.8

1.11

173

1135

(3002173) Hemoglobin [Mass/volume] in Arterial blood

189

1188

1.67

9.16

10.3

8.5

g/l

118.5

120.1

0.51

181

1148

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.79

9.07

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.79

9.07

1.1

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

492

2.01

9.05

4.3

2.6

g/l

3.6

3.8

0.91

362

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

493

2.00

9.00

4.3

2.6

g/l

7.4

0.20

378

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

493

2.00

9.00

4.3

2.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

207

2.56

8.93

1.2

—

(3037121) Protein [Mass/volume] in Urine

489

2.00

8.86

4.4

3.4

g/l

0.3

0.07

205

(3017704) Immunofixation for Urine

3.63

8.85

1.4

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1500

14028

1.61

8.80

28.1

15.6

mmol/l

4.0

0.25

1474

13617

(3024354) Oxygen [Partial pressure] in Venous blood

169

1044

1.69

8.74

6.8

3.6

kpa

4.8

4.6

0.50

163

1006

(3019225) pH of Specimen

202

1308

1.62

8.70

7.6

4.1

—

(3017732) Neutrophils [#/volume] in Blood

158

963

1.71

8.59

4.3

2.8

e9/l

4.2

4.1

0.19

119

755

(3022217) INR in Platelet poor plasma by Coagulation assay

235

1585

1.56

8.51

21.6

25.2

inr

1.4

1.3

0.46

203

(4035726)

181

1147

1.65

8.49

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

160

2.73

8.45

1.6

1.7

55.9

57.0

0.06

107

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.91

8.43

1.3

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

155

2.75

8.38

2.9

2.0

33.2

32.4

0.65

155

(3026389) Candida sp identified in Specimen by Organism specific culture

197

2.53

8.27

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

286

2.25

8.14

1.6

1.2

u/ml

56.2

54.1

—

(3042631) Mycobacterium sp identified in Specimen

176

2.60

8.04

3.8

2.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

429

2.01

8.03

3.5

2.8

g/l

1.8

1.3

0.30

377

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1207

10888

1.38

7.97

4.8

4.1

pmol/l

14.9

14.7

1.72

1101

9930

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

169

1070

1.64

7.96

7.0

3.5

mmol/l

1.2

0.43

150

915

(3036489) Thrombin time

523

1.91

7.93

2.4

2.5

21.7

21.4

0.19

466

(3003327) Ova and parasites identified in Stool by Light microscopy

462

1.95

7.79

1.6

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

306

2.17

7.70

1.9

1.7

e6/l

30333.3

13122.2

0.78

224

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

129

2.83

7.61

1.1

1.2

u/l

70.5

52.7

0.40

(3014111) Lactate [Moles/volume] in Serum or Plasma

175

1133

1.61

7.53

9.1

7.3

mmol/l

1.6

1.4

1.00

168

1085

(3012501) Base excess in Blood by calculation

270

2.23

7.50

5.6

4.3

mmol/l

2.3

2.6

0.38

181

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.57

7.43

2.4

3.6

—

(40767503) Oxygen content in Capillary blood by calculation

252

2.26

7.41

3.3

2.4

15.8

16.2

0.30

128

(21494890) Protein electrophoresis panel - 24 hour Urine

132

2.76

7.31

3.0

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

396

1.99

7.24

3.7

3.2

u/ml

0.3

0.4

0.64

220

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

460

1.92

7.22

4.7

2.7

g/l

10.3

0.04

393

(3013512) EKG study

475

3765

1.36

7.21

4.7

3.7

—

(3042733) HLA Ab [Presence] in Serum

4.74

7.17

4.9

4.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

7.73

7.12

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1010

8941

1.32

7.09

4.7

3.0

u/l

56.7

45.1

2.99

947

8357

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

162

1046

1.61

7.05

3.8

2.9

ng/l

164.6

205.8

0.74

147

956

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

422

1.94

7.01

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

162

1048

1.60

7.00

4.0

2.7

ml/min/173m2

63.2

66.3

0.44

414

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

372

2853

1.39

6.88

1.7

pmol/l

116346594.7

30297037.5

0.83

312

2360

(3012516) Albumin [Mass/volume] in Urine

464

3693

1.35

6.79

3.6

3.3

mg/l

569.8

291.4

0.51

286

2331

(3026250) Tacrolimus [Mass/volume] in Blood

3.65

6.76

44.3

29.1

ug/l

8.3

6.9

0.52

(3007930) Methemoglobin/Hemoglobin.total in Blood

508

1.84

6.72

7.0

6.1

1.0

0.9

1.24

479

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

150

2.57

6.71

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

2.50

6.70

2.7

2.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

380

1.96

6.66

3.5

2.7

g/l

0.1

0.0

0.37

350

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

162

1061

1.58

6.65

5.3

3.8

ng/l

107.4

84.6

1.60

141

932

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

466

1.87

6.65

3.7

2.7

g/l

3.2

0.02

368

(3052851) Hemolysis interference index of Serum or Plasma

409

1.92

6.62

3.3

—

(3009508) Creatinine [Moles/volume] in Urine

505

4085

1.34

6.61

3.6

3.2

mmol/l

7.0

7.5

2.01

423

3438

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.29

6.58

2.0

4.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.28

6.56

1.6

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

512

1.82

6.56

7.0

6.1

1.5

1.6

0.16

482

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

117

2.77

6.55

1.3

—

(3021788) Differential panel - Synovial fluid

227

2.24

6.52

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

399

1.92

6.43

1.3

1.5

ug/g

254.5

292.6

0.88

229

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

6.14

6.43

6.5

2.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

467

3750

1.34

6.39

4.8

3.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

111

668

1.71

6.36

12.0

11.0

—

(3044290) Cell count panel - Cerebral spinal fluid

283

2.09

6.33

1.7

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.19

6.30

1.6

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

482

3898

1.33

6.26

4.5

4.0

mg/mmol

9.1

8.6

0.09

299

2438

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

132

2.61

6.22

1.3

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

156

2.47

6.21

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.82

6.11

2.8

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

403

3187

1.35

6.06

1.7

1.5

nmol/l

19.3

20.8

1.11

350

2702

(3004616) Nuclear Ab [Presence] in Serum

158

2.44

6.05

1.5

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.36

6.00

1.1

1.2

—

(40761511) CBC panel - Blood by Automated count

1517

14427

1.50

5.99

23.6

12.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

172

2.36

5.93

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

396

1.88

5.93

7.0

7.4

mmol/l

1.2

1.3

0.61

348

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

230

2.16

5.92

2.4

2.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.55

5.89

1.1

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.97

5.85

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

143

2.48

5.80

1.7

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

174

2.33

5.79

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

174

2.33

5.79

1.6

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

156

2.40

5.74

1.8

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

109

2.69

5.67

1.7

1.5

39.2

34.3

0.27

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

208

2.20

5.66

1.4

u/l

25.3

24.9

0.03

172

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

2.78

5.64

1.5

1.1

u/ml

19.4

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.91

5.63

1.3

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

5.91

5.63

6.9

2.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

418

1.83

5.61

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.56

5.61

6.7

4.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

182

1271

1.48

5.58

2.8

2.3

u/l

37.1

39.3

0.12

158

1070

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

116

2.61

5.56

4.3

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

171

2.31

5.55

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

171

2.31

5.55

1.6

1.4

—

(40761536) Microorganisms panel - Urine sediment

175

1214

1.49

5.54

6.6

3.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1361

12743

1.35

5.51

21.8

12.3

ml/min/173m2

81.5

82.6

0.93

1177

10387

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

108

672

1.65

5.49

6.3

4.8

mmol/l

24.7

23.9

1.94

614

(3005988) Vibrio sp identified in Specimen by Organism specific culture

172

2.30

5.48

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1024

9239

1.27

5.46

3.6

3.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1365

12792

1.35

5.45

5.7

4.8

mu/l

2.0

0.07

1262

11756

(4010399)

138

914

1.56

5.42

1.5

1.4

—

(3036603) Volume of Urine

2.84

5.42

1.6

1.5

1969.4

2020.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

112

2.62

5.40

2.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

410

1.82

5.34

1.5

u/l

13.0

10.2

0.80

331

(40768446) Kidney Pathology biopsy report

3.57

5.33

2.1

1.6

—

(36660697) Celiac disease serology panel - Serum

164

1133

1.50

5.30

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

355

1.86

5.21

3.5

2.7

g/l

0.0

0.00

328

(3014765) Yersinia sp identified in Stool by Organism specific culture

421

1.79

5.20

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1525

14582

1.47

5.18

18.8

10.0

u/l

26.9

25.3

2.26

1490

14070

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

109

2.60

5.14

1.2

1.1

—

(4034850)

423

1.78

5.12

11.0

9.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

583

1.67

5.11

4.5

2.9

0.7

0.6

1.82

561

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

211

2.11

5.08

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

358

1.85

5.08

3.6

2.7

g/l

0.0

0.00

329

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.92

5.04

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.92

5.04

1.4

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

316

1.90

5.02

3.4

3.3

mmol/l

24.5

24.9

0.36

280

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

156

1080

1.49

5.00

2.3

2.5

ug/l

6.2

7.0

0.26

130

940

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

111

2.55

4.97

1.1

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

428

1.76

4.94

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.68

4.93

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

3.68

4.93

1.1

—

(3024471) HLA-A [Type]

3.68

4.93

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.14

4.92

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.14

4.92

1.6

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

106

2.57

4.89

1.5

1.1

u/ml

65.0

81.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

201

2.12

4.89

4.5

5.4

umol/l

382.2

369.5

0.22

178

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.02

4.78

1.3

—

(3003181) Sodium [Moles/volume] in Urine

237

2.01

4.77

1.3

1.4

mmol/l

70.1

66.2

0.24

196

(3039000) Anion gap in Blood

281

1.91

4.67

8.2

8.7

mmol/l

10.6

11.2

0.62

256

(3000093) Morphology [Interpretation] in Blood Narrative

121

2.42

4.65

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

115

2.46

4.64

1.7

1.2

u/ml

0.5

0.6

0.02

(3021901) Oxygen saturation in Capillary blood

219

2.04

4.64

3.1

2.8

—

(3018572) Chloride [Moles/volume] in Blood

282

1.91

4.63

8.2

8.7

mmol/l

105.7

105.1

0.41

257

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

10.04

4.52

1.9

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

208

2.05

4.49

1.3

1.2

u/l

49.5

27.1

0.40

180

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

120

806

1.53

4.46

11.9

9.1

1.4

0.45

115

799

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1303

12231

1.28

4.45

6.6

5.5

mmol/mol

39.9

39.5

0.85

1201

11324

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

367

1.77

4.43

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.71

4.42

1.6

1.5

u/l

3.6

7.9

0.71

(40768804) Tissue Pathology biopsy report

638

5538

1.24

4.42

2.3

2.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

280

1.88

4.40

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

280

1.88

4.40

1.3

1.4

—

(3022145) Colonoscopy Study observation

199

1479

1.39

4.37

1.4

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

399

1.73

4.35

3.7

2.5

g/l

37.9

37.6

0.15

344

(3008898) HLA-B27 [Presence]

499

1.65

4.34

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

185

2.08

4.27

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

394

1.73

4.26

5.9

5.5

mg/l

1.5

0.01

365

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.71

4.26

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

118

800

1.51

4.21

12.1

9.2

0.8

0.7

1.24

113

794

(3047189) Immunofixation for 24 hour Urine

2.88

4.06

3.6

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

1242

11640

1.25

4.00

29.3

16.4

13.9

13.6

8.78

1232

11378

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.49

3.97

1.4

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

2.73

3.92

1.7

1.4

umol/l

14.7

27.4

1.62

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.27

3.91

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

312

2523

1.29

3.87

4.0

2.9

mmol/l

2.5

0.65

275

2220

(3000492) Spirometry study

173

1285

1.39

3.82

1.5

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.42

3.73

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

4.02

3.70

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.39

3.65

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.13

3.65

1.2

—

(40768795) Lymph node Pathology biopsy report

129

2.19

3.65

1.3

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

374

1.68

3.64

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.62

3.64

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.68

3.64

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

115

801

1.47

3.63

2.1

2.2

nmol/l

12.1

12.2

0.04

103

700

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.87

3.63

5.1

1.9

ug/l

18.2

157.1

0.50

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.27

3.62

1.2

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.66

3.56

1.3

1.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

7.80

3.56

4.4

5.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.06

3.53

1.7

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.32

3.51

1.1

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.19

3.49

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

667

1.50

3.48

12.5

9.9

mmol/l

24.3

0.08

623

(3009871) Measles virus Ab [Titer] in Serum

3.35

3.48

1.6

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.00

3.41

1.2

—

(3045414) Leukocytes [Presence] in Urine

605

1.52

3.40

2.0

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

202

1568

1.33

3.38

1.8

1.7

1.5

1.4

0.07

178

1384

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

154

2.03

3.36

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

203

1.89

3.36

1.3

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.72

3.35

1.2

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.33

3.34

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

495

1.56

3.31

1.5

1.3

miu/ml

217.4

244.1

0.22

245

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

121

869

1.42

3.28

3.0

3.3

pmol/l

4.4

4.5

0.45

106

762

(3010144) Erythrocytes [#/volume] in Synovial fluid

122

2.15

3.26

1.5

1.3

e6/l

14186.7

96177.6

0.77

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.79

3.25

1.1

iu/ml

134.8

181.2

0.65

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

317

1.69

3.24

1.8

1.7

e6/l

32.4

14.4

0.41

249

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

317

1.69

3.24

1.8

e6/l

58.3

1417.3

0.92

258

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.76

3.24

2.7

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

143

2.05

3.22

3.2

3.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

3.17

3.21

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.17

3.21

1.3

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

3.59

3.20

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

232

1851

1.29

3.18

1.3

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

6.38

3.18

1.7

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.97

3.13

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

201

1.86

3.13

1.8

1.5

—

(3000012) Reticulocyte production index

2.48

3.13

2.0

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

204

1604

1.31

3.12

11.2

7.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

132

2.06

3.07

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.90

3.02

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.85

3.02

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.76

2.99

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

10.02

2.98

1.6

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

171

1321

1.33

2.97

4.2

4.1

ug/l

26.4

19.8

0.20

137

1068

(3024932) HLA-DR beta [Type]

3.01

2.97

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.16

2.93

1.1

1.3

—

(3007461) Platelets [#/volume] in Blood

1580

15400

1.40

2.93

37.6

19.9

e9/l

255.1

253.6

0.36

1555

14999

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.84

2.92

3.3

3.6

—

29.8

—

(3051651) Icteric interference index of Serum or Plasma

2.26

2.87

3.6

3.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.40

2.87

1.0

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.69

2.87

2.0

1.6

—

(3044889) 12 lead EKG panel

1002

9331

1.18

2.85

4.5

3.7

—

(3024731) MCV [Entitic volume]

1580

15408

1.39

2.84

37.3

19.8

91.0

90.8

1.59

1565

15193

(3035941) MCH [Entitic mass]

1580

15410

1.39

2.82

37.3

19.8

30.2

0.39

1566

15193

(3026361) Erythrocytes [#/volume] in Blood

1580

15411

1.38

2.81

37.5

19.9

e12/l

4.4

4.5

10.40

1555

14967

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.46

2.79

1.0

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

203

1621

1.29

2.78

4.7

4.3

32.0

32.4

0.18

150

1101

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.28

2.77

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.24

2.77

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.24

2.77

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

1580

15415

1.38

2.76

37.6

19.9

e9/l

7.0

6.7

2.89

1553

14967

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.87

2.75

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

1580

15417

1.38

2.74

37.7

20.0

g/l

131.2

134.3

13.32

1567

15198

(3006184) Hemoglobin [Mass/volume] in Capillary blood

279

1.67

2.72

2.5

2.3

g/l

124.2

129.5

0.75

209

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.23

2.68

1.3

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.23

2.68

1.3

1.1

—

(4268621)

140

1.94

2.66

2.3

2.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

113

2.05

2.62

1.2

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.61

2.57

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

379

1.55

2.56

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

128

1.97

2.56

8.4

3.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

7.16

2.55

3.0

1.4

mg/l

3.0

4.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.12

2.49

1.4

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1324

12698

1.20

2.41

4.3

3.8

mmol/l

1.3

1.75

1209

11639

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.95

2.41

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.76

2.37

2.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.62

2.36

1.0

1.1

u/ml

2.4

16.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.62

2.36

1.2

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

148

1.84

2.29

1.1

1.2

nmol/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

641

1.39

2.28

2.5

2.2

u/l

1429.2

5391.1

1.90

271

(3042517) Benzodiazepines panel - Urine

4.63

2.27

4.2

1.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

278

1.60

2.27

3.0

3.2

umol/l

31.6

36.0

0.71

237

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.03

2.26

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.90

2.25

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.90

2.25

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

105

790

1.35

2.23

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

210

1.68

2.21

1.3

1.2

u/ml

4.9

5.3

0.05

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

107

1.97

2.20

1.0

1.1

—

(3048879) Bone marrow aspiration report

2.79

2.20

1.6

1.8

—

(3045424) Erythrocytes [Presence] in Urine

226

1.65

2.19

1.7

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1356

13073

1.19

2.13

5.2

4.3

mmol/l

6.0

5.9

1.14

1235

11897

(1761482) Bacteria [#/volume] in Urine by Culture

348

1.51

2.11

6.0

4.4

—

(3044927) Protein electrophoresis panel - Urine

145

1.81

2.11

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

109

1.94

2.10

3.0

2.3

575.7

626.0

0.25

(40768441) Liver Pathology biopsy report

102

1.97

2.10

2.1

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

276

1.57

2.10

1.1

u/ml

5.9

6.8

0.12

158

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.21

2.09

2.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.21

2.09

2.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.21

2.09

2.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.91

2.07

1.1

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.91

2.07

1.2

1.1

73.9

96.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.91

2.07

2.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

191

1.69

2.07

2.2

2.5

u/ml

4.0

26.6

0.55

178

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.92

2.06

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.92

2.06

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.41

2.02

1.5

1.6

—

1224630.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

118

1.88

2.02

2.5

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

263

1.57

2.01

1.4

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

111

1.90

2.01

1.1

1.2

—

(4015189)

2.64

2.01

4.1

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

178

1461

1.24

1.99

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

119

1.86

1.97

1.9

1.3

e6/l

21571.1

90675.5

0.70

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.96

1.4

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

113

1.87

1.92

1.1

1.2

mg/l

45.7

40.4

0.16

(3023323) Follitropin [Units/volume] in Serum or Plasma

708

1.33

1.87

1.5

1.4

iu/l

25.9

26.9

0.11

603

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

518

1.39

1.87

1.5

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.77

1.79

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.77

1.79

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.77

1.79

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.77

1.79

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.74

3.8

5.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.23

1.74

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.51

1.74

2.2

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

155

1.69

1.73

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.92

1.72

4.9

5.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.85

1.71

1.6

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

148

1.70

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.30

1.70

4.5

2.5

—

(3000330) Specific gravity of Urine by Test strip

677

1.32

1.68

5.3

3.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.39

1.67

3.3

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1390

13498

1.17

1.67

5.1

4.7

mmol/l

2.7

1.32

1278

12426

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1368

13269

1.16

1.66

4.7

4.2

mmol/l

4.6

4.7

2.57

1267

12302

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

697

1.31

1.64

2.5

2.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.58

1.61

1.6

1.1

u/l

9.6

29.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.58

1.61

8.6

5.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.21

1.57

1.0

1.4

75.4

92.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

216

1.54

1.2

1.1

iu/ml

14.0

85.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1357

13175

1.15

1.54

4.6

4.2

mmol/l

1.4

1.5

3.96

1247

12137

(3015183) Erythrocyte sedimentation rate

1.98

1.54

1.3

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

307

1.44

1.53

1.1

u/ml

0.7

1.8

1.20

132

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

349

1.42

1.52

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

836

0.74

1.52

1.3

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.00

1.52

0.0

1.4

—

14.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

108

1.77

1.51

1.0

1.1

mg/l

290.9

245.6

0.31

(3024869) Neuronal Ab [Presence] in Serum

2.86

1.50

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

2.01

1.48

4.5

2.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.01

1.48

1.7

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

445

1.36

1.48

1.6

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

268

1.47

1.1

u/ml

0.6

1.6

0.88

126

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.12

1.44

1.0

1.1

77.2

90.1

—

(4024509)

125

1.69

1.44

1.1

1.5

—

(4211845)

1.98

1.43

3.2

2.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.98

1.43

2.7

2.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.80

1.43

1.0

1.1

iu/ml

11.1

8.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.74

1.43

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

110

1.74

1.43

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.74

1.43

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.83

1.41

1.3

1.0

u/ml

12.2

0.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.86

1.40

1.4

1.1

u/ml

9.3

0.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.95

1.38

1.5

1.6

—

11.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.84

1.35

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

479

1.33

1.35

3.9

3.3

u/ml

7820.9

3068.8

0.28

410

(3003434) Protein [Mass/volume] in Pleural fluid

151

1.60

1.35

1.7

1.4

g/l

32.3

32.0

0.04

135

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

196

0.51

1.35

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

175

1.55

1.34

1.4

—

(21494755) Public health laboratory ask at order entry panel

105

1282

0.81

1.34

1.4

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

1.32

0.0

1.5

—

(3023410) Appearance of Cerebral spinal fluid

152

1.59

1.32

2.5

2.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

355

0.64

1.30

1.4

—

(3005033) Fetal Nuchal fold Thickness US

352

0.65

1.26

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

203

1.49

1.25

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

228

1.46

1.24

1.4

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

362

0.66

1.24

1.4

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

100

1.71

1.23

2.0

1.4

promille

0.6

1.2

1.29

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

163

1.54

1.23

2.4

2.3

mg/l

16.8

24.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

229

1.45

1.22

1.4

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

213

1.46

1.21

1.4

1.2

u/ml

2.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.84

1.19

1.7

1.2

u/l

9.3

11.8

0.45

(4306422)

189

1.49

1.19

1.4

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

370

0.67

1.18

2.0

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.11

1.18

2.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

543

1.28

1.18

2.4

1.6

mu/l

398.4

306.3

0.95

489

(3014133) Dog dander IgE Ab [Units/volume] in Serum

206

1.46

1.18

1.1

1.0

u/ml

5.9

5.3

0.11

(3009542) Hematocrit [Volume Fraction] of Blood

1313

12787

1.12

1.17

25.1

14.6

38.9

39.6

1.78

903

9306

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.94

1.17

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

377

1.34

1.16

2.1

1.9

iu/l

5.1

0.02

134

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

3.1

—

1.9

—

(3011288) Drugs identified in Urine by Screen method

421

1.32

1.16

3.4

2.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.50

1.15

2.2

1.3

—

(3012441) Differential panel - Pleural fluid

118

1.62

1.15

1.8

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

346

3152

1.12

1.14

5.2

5.1

ug/l

2.9

3.1

0.10

307

2796

(3010726) Horse dander IgE Ab [Units/volume] in Serum

258

1.40

1.14

1.1

u/ml

5.3

3.1

0.32

(3003694) ABO and Rh group [Type] in Blood

433

3996

1.11

1.13

1.5

—

(40757373) Influenza virus identified in Isolate

2.34

1.12

2.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.34

1.12

1.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.34

1.12

1.9

1.3

—

(3006462) Nitrate [Presence] in Urine

1.90

1.12

3.5

2.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

217

1.44

1.11

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

783

1.23

1.11

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.71

1.11

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.71

1.11

1.0

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

184

1.47

1.11

1.0

1.1

u/ml

5.8

7.1

0.16

(3013293) Extractable nuclear Ab [Presence] in Serum

2.38

1.09

3.6

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.82

1.09

1.5

1.1

miu/ml

1667.4

1630.1

0.03

(3024263) Appearance of Synovial fluid

1.87

1.07

1.7

—

(3005570) Glucose [Moles/volume] in Urine

145

1.52

1.06

1.5

2.2

—

(3045788) Cell count panel - Pleural fluid

113

1.60

1.05

1.9

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

212

1.42

1.04

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.28

1.03

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

1.61

1.03

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

852

0.80

1.03

1.6

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

139

1.52

1.00

1.1

—

(44813793)

1.62

1.00

1.0

—

(40758292) HTLV I+II Ab panel - Serum

2.18

0.98

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.80

0.96

1.9

1.3

—

(3006270) Folate [Moles/volume] in Blood

108

1.58

0.96

1.1

nmol/l

268.8

385.0

1.95

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.23

0.93

1.8

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

218

1.38

0.91

1.3

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.07

0.89

1.3

2.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.07

0.89

2.7

5.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

315

1.31

0.89

3.4

2.5

ug/min

61.3

104.4

0.54

194

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

177

1.42

0.88

1.1

1.0

u/ml

0.1

0.4

0.76

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.91

0.88

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

539

1.23

0.88

2.7

1.6

mg/l

4.5

3.3

0.67

384

(3013139) Helicobacter pylori Ag [Presence] in Stool

105

899

1.18

0.87

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

256

1.33

0.85

3.7

3.2

nmol/l

0.8

0.04

202

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.74

0.82

2.1

1.4

ug/l

8.3

9.2

—

(3019977) pH of Arterial blood

1.70

0.82

1.7

3.4

7.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

330

0.72

0.82

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

275

2524

1.11

0.82

4.3

20.9

21.3

0.16

141

1236

(3022689) Creatine [Moles/volume] in Urine

1.88

0.82

2.3

1.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.88

0.82

1.5

1.2

mmol/l

2.3

3.5

—

(3002256) Pathology report gross observation

194

1750

1.12

0.79

1.3

—

(3020491) Glucose [Moles/volume] in Blood

1.54

0.78

5.2

1.7

mmol/l

6.2

6.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

181

1631

1.12

0.76

1.9

1.7

—

(3027944) Amphetamines [Presence] in Urine

609

1.19

0.72

2.8

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

190

1725

1.11

0.71

2.2

2.1

—

(3027008) Opiates [Presence] in Urine

619

1.19

0.71

2.8

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

274

2535

1.10

0.71

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

621

1.18

0.69

2.8

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.53

0.69

2.9

1.7

—

(3016879) Cocaine [Presence] in Urine

576

1.19

0.67

2.9

2.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

102

1.47

0.67

2.6

1.5

g/l

0.9

1.0

0.19

102

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

374

3516

1.08

0.67

1.7

mmol/l

1.4

0.72

313

2962

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

473

0.80

0.67

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

153

1.38

0.67

4.0

2.5

—

(3000764) Benzodiazepines [Presence] in Urine

615

1.18

0.66

2.8

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

115

1020

1.14

0.64

1.2

iu/ml

80.3

140.2

2.13

385

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.73

0.64

1.0

u/ml

63.7

40.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.73

0.64

1.2

—

46.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

435

0.80

0.62

1.5

1.4

—

(3035880) pH of Pleural fluid

1.59

0.61

1.3

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

105

1183

0.88

0.61

1.4

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.61

1.6

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.67

0.61

2.0

3.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

434

0.80

0.61

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

433

0.80

0.60

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.50

0.59

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

432

0.81

0.59

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

273

1.25

0.58

3.2

2.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.48

0.57

1.6

—

(3025130) Human papilloma virus identified in Specimen

194

1.29

0.56

1.6

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

276

1.24

0.54

2.8

1.8

nmol/l

1.3

0.8

1.17

230

(40768806) Pleura Pathology biopsy report

125

1.36

0.53

2.2

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

516

1.17

0.53

1.5

1.4

—

(3004451) EKG impression Narrative

1.45

0.53

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

554

0.84

0.52

1.6

1.4

—

(3034426) Prothrombin time (PT)

1.50

0.51

1.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

157

0.70

0.51

1.2

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

197

1828

1.09

0.51

3.4

3.1

ug/l

0.8

0.04

145

1216

(3014051) Protein [Presence] in Urine by Test strip

315

1.21

0.51

2.2

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.50

2.2

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.50

2.2

2.6

—

(3029075) Extractable nuclear Ab panel - Serum

1.56

0.49

1.1

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.45

0.48

6.1

7.2

—

(3051593) INR in Capillary blood by Coagulation assay

1.40

0.45

7.9

9.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

743

1.12

0.44

1.8

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

488

1.15

0.44

2.9

1.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.61

0.43

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

425

0.84

0.43

1.6

—

(3024928) Oxygen saturation in Venous blood

285

1.20

0.42

2.9

3.6

—

(4027681)

1.36

0.41

1.4

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.52

0.41

4.4

6.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.41

0.0

4.8

—

(3049717) Cytology report of Urine Cyto stain

464

1.15

0.41

1.8

2.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.33

0.40

1.3

1.0

—

(4094501)

334

1.17

0.39

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.43

0.39

1.4

1.1

pmol/l

237.2

287.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.43

0.39

4.4

6.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.2

—

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.39

0.0

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.37

0.38

1.0

—

(3020650) Glucose [Presence] in Urine

1.39

0.38

1.0

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.33

0.37

3.6

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.35

0.37

1.2

2.0

—

2.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

302

1.16

0.34

1.3

1.7

nmol/l

42.6

40.4

0.23

291

(3003338) MCHC [Mass/volume]

1196

11811

1.04

0.33

31.1

17.5

g/l

331.0

332.3

4.81

1183

11720

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1.33

0.32

10.8

11.6

mmol/l

0.7

0.6

0.31

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

119

1.26

0.31

1.1

1.5

mmol/l

8.3

12.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

229

0.83

0.30

1.5

1.6

—

(3017569) Oxygen content in Arterial blood

1.25

0.29

1.1

3.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

113

1.24

0.26

1.4

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

357

1.12

0.26

1.2

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.32

0.23

1.6

3.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

209

1.15

0.23

1.0

u/ml

1.7

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

198

1905

1.04

0.21

2.4

2.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

11.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

42.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

104

0.77

0.21

1.4

1.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

7.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.20

0.19

3.0

1.4

—

(3022621) pH of Urine by Test strip

902

1.06

0.18

2.7

2.8

—

(4198724)

1.21

0.18

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

237

0.88

0.17

1.5

nmol/l

0.2

0.3

1.54

187

(3044242) Glucose [Moles/volume] in Arterial blood

0.71

0.16

1.0

2.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.10

0.15

2.4

1.7

u/field

0.3

4.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.77

0.15

1.0

1.4

nmol/l

28.3

34.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

245

0.90

0.15

1.5

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

912

1.04

0.13

1.9

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.18

0.12

1.6

1.5

—

(4146454)

133

1.13

0.12

2.8

—

(1002224) Polysomnography panel

517

0.95

0.11

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

117

1134

1.03

0.11

2.1

1.9

—

(1761868) Lipid panel - Serum or Plasma

475

4691

1.02

0.11

3.0

2.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.16

0.11

1.6

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

290

0.93

0.10

3.6

3.4

mg/l

21.1

24.5

0.32

185

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

494

0.95

0.10

1.4

—

(40768793) Breast Pathology biopsy report

351

1.06

0.08

1.4

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

0.86

0.07

1.7

1.3

nmol/l

119.0

140.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.85

0.07

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.07

0.07

1.1

1.4

—

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

157

1.08

0.07

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

224

0.94

0.06

1.9

2.2

umol/l

4.8

5.9

0.37

163

(3038177) Helicobacter pylori Ab [Presence] in Serum

218

1.06

0.05

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

199

1.06

0.04

1.2

—

(3011648) Oxygen content in Venous blood

109

0.92

0.04

3.9

4.3

12.3

11.2

—

109

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

523

0.97

0.04

1.5

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

154

1555

0.99

0.03

1.7

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

126

0.95

0.00

1.1

—

(4281824)

152

0.99

0.00

1.3

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.00

0.00

1.2

1.5

—

(4038314)

0.00

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.3

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

4.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1766.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.96

0.00

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.85

0.00

1.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

44.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.91

0.00

4.1

14.0

nmol/l

501.4

824.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_AGEP – Acute generalized exanthematous pustulosis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acute generalized exanthematous pustulosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Acute generalized exanthematous pustulosis (L12_AGEP)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints